BackImunon Overview

Imunon Accounts Payable

Track Imunon's accounts payable ($960K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$964590.00
99.95% YoYΔ $-1.86B vs prior year quarter

Peer average / median

Loading

Imunon Accounts Payable History

Loading

Imunon vs. peers: Accounts Payable Comparison

Loading

Imunon Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Imunon (IMNN) FAQ

As of the most recent data (March 2026), IMNN shows a accounts payable of $960K. That compares with $1.9B in the prior-year period — down 99.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMNN's accounts payable is now $960K (was $1.9B) — a 99.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Imunon is outperforming or lagging.

Tracking IMNN's accounts payable over time shows whether Imunon is scaling, shrinking, or reshaping that part of the business. The current reading is $960K That compares with $1.9B in the prior-year period — down 99.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Imunon's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $960K) with ownership activity and broader fundamentals.

Imunon's accounts payable is $960K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.